119 related articles for article (PubMed ID: 37052835)
1. PFOA, PFHxA and C6O4 differently modulate the expression of CXCL8 in normal thyroid cells and in thyroid cancer cell lines.
Coperchini F; De Marco G; Croce L; Denegri M; Greco A; Magri F; Tonacchera M; Imbriani M; Rotondi M; Chiovato L
Environ Sci Pollut Res Int; 2023 May; 30(23):63522-63534. PubMed ID: 37052835
[TBL] [Abstract][Full Text] [Related]
2. Do PFCAs drive the establishment of thyroid cancer microenvironment? Effects of C6O4, PFOA and PFHxA exposure in two models of human thyroid cells in primary culture.
Coperchini F; Greco A; Croce L; Teliti M; Calì B; Chytiris S; Magri F; Rotondi M
Environ Int; 2024 May; 187():108717. PubMed ID: 38728818
[TBL] [Abstract][Full Text] [Related]
3. The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro.
Coperchini F; Croce L; Pignatti P; Ricci G; Gangemi D; Magri F; Imbriani M; Rotondi M; Chiovato L
J Endocrinol Invest; 2021 Aug; 44(8):1625-1635. PubMed ID: 33315184
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Reduces Thyroid Cancer Cells Migration Independently From the Modulation of CCL2 and CXCL8 Chemokines Secretion.
Coperchini F; Greco A; Croce L; Petrosino E; Grillini B; Magri F; Chiovato L; Rotondi M
Front Endocrinol (Lausanne); 2022; 13():876397. PubMed ID: 35498406
[TBL] [Abstract][Full Text] [Related]
5. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug.
Coperchini F; Greco A; Croce L; Pignatti P; Muzza M; Petrosino E; Teliti M; Magri F; Rotondi M
Biomed Pharmacother; 2024 Jan; 170():115974. PubMed ID: 38056240
[TBL] [Abstract][Full Text] [Related]
6. The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes.
Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Magri F; Chiovato L; Rotondi M
Oncotarget; 2019 Nov; 10(60):6432-6443. PubMed ID: 31741708
[TBL] [Abstract][Full Text] [Related]
7. The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors.
Coperchini F; Croce L; Denegri M; Awwad O; Ngnitejeu ST; Muzza M; Capelli V; Latrofa F; Persani L; Chiovato L; Rotondi M
Sci Rep; 2019 Mar; 9(1):4390. PubMed ID: 30867499
[TBL] [Abstract][Full Text] [Related]
8. The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.
Awwad O; Coperchini F; Pignatti P; Denegri M; Massara S; Croce L; Di Buduo CA; Abbonante V; Balduini A; Chiovato L; Rotondi M
J Endocrinol Invest; 2018 Nov; 41(11):1275-1282. PubMed ID: 29546654
[TBL] [Abstract][Full Text] [Related]
9. Comparative Evaluation of the Effects of Legacy and New Generation Perfluoralkyl Substances (PFAS) on Thyroid Cells
De Toni L; Di Nisio A; Rocca MS; Pedrucci F; Garolla A; Dall'Acqua S; Guidolin D; Ferlin A; Foresta C
Front Endocrinol (Lausanne); 2022; 13():915096. PubMed ID: 35813651
[TBL] [Abstract][Full Text] [Related]
10. Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.
Coperchini F; Pignatti P; Leporati P; Carbone A; Croce L; Magri F; Chiovato L; Rotondi M
Endocrine; 2016 Oct; 54(1):123-128. PubMed ID: 26450713
[TBL] [Abstract][Full Text] [Related]
11. Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation.
Rotondi M; Coperchini F; Awwad O; Pignatti P; Di Buduo CA; Abbonante V; Magri F; Balduini A; Chiovato L
Mediators Inflamm; 2016; 2016():8512417. PubMed ID: 27555670
[TBL] [Abstract][Full Text] [Related]
12. Perfluoroalkylated substances (PFAS) affect neither estrogen and androgen receptor activity nor steroidogenesis in human cells in vitro.
Behr AC; Lichtenstein D; Braeuning A; Lampen A; Buhrke T
Toxicol Lett; 2018 Jul; 291():51-60. PubMed ID: 29601859
[TBL] [Abstract][Full Text] [Related]
13. Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug.
Rotondi M; Coperchini F; Pignatti P; Magri F; Chiovato L
J Clin Endocrinol Metab; 2015 Mar; 100(3):E427-32. PubMed ID: 25590211
[TBL] [Abstract][Full Text] [Related]
14. The new PFAS C6O4 and its effects on marine invertebrates: First evidence of transcriptional and microbiota changes in the Manila clam Ruditapes philippinarum.
Bernardini I; Matozzo V; Valsecchi S; Peruzza L; Rovere GD; Polesello S; Iori S; Marin MG; Fabrello J; Ciscato M; Masiero L; Bonato M; Santovito G; Boffo L; Bargelloni L; Milan M; Patarnello T
Environ Int; 2021 Jul; 152():106484. PubMed ID: 33740673
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle alterations due to perfluoroalkyl substances PFOS, PFOA, PFBS, PFBA and the new PFAS C6O4 on bottlenose dolphin (Tursiops truncatus) skin cell.
Otero-Sabio C; Giacomello M; Centelleghe C; Caicci F; Bonato M; Venerando A; Graïc JM; Mazzariol S; Finos L; Corain L; Peruffo A
Ecotoxicol Environ Saf; 2022 Oct; 244():113980. PubMed ID: 36057203
[TBL] [Abstract][Full Text] [Related]
16. Varied thyroid disrupting effects of perfluorooctanoic acid (PFOA) and its novel alternatives hexafluoropropylene-oxide-dimer-acid (GenX) and ammonium 4,8-dioxa-3H-perfluorononanoate (ADONA) in vitro.
Zhang S; Chen K; Li W; Chai Y; Zhu J; Chu B; Li N; Yan J; Zhang S; Yang Y
Environ Int; 2021 Nov; 156():106745. PubMed ID: 34246126
[TBL] [Abstract][Full Text] [Related]
17. BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.
Zhou D; Li Z; Bai X
Med Sci Monit; 2017 Nov; 23():5321-5329. PubMed ID: 29117154
[TBL] [Abstract][Full Text] [Related]
18. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
19. Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.
Nucera C; Nehs MA; Nagarkatti SS; Sadow PM; Mekel M; Fischer AH; Lin PS; Bollag GE; Lawler J; Hodin RA; Parangi S
Oncologist; 2011; 16(3):296-309. PubMed ID: 21355020
[TBL] [Abstract][Full Text] [Related]
20. Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?
Coperchini F; Greco A; Rotondi M
J Endocrinol Invest; 2024 Mar; ():. PubMed ID: 38522066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
